Development and validation of a nomogram model for predicting diabetic foot in type 2 diabetes
PeerJ · 21.07.2026 · 14 · e21584
DOI: 10.7717/peerj.21584 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift PeerJ, online erschienen am 21.07.2026. Verfasst von Chuanqing Xie und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, The First Affiliated Hospital of Xi'an Medical University, Xi'an Medical University, Xi'an, Shanxi, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Nomograms, Diabetic Foot. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Diabetes mellitus, Diabetisches Fußsyndrom
Abstract (Originalsprache)
Background
Diabetic foot (DF) represents a serious complication associated with type 2 diabetes mellitus (T2DM), characterized by elevated rates of morbidity and mortality, alongside substantial healthcare expenditures. Early detection and intervention are essential for enhancing patient prognosis. The objective of this research is to establish a nomogram model for predicting diabetic foot (DF) risk in type 2 diabetes (T2DM).
Methods
We conducted a retrospective analysis of 450 individuals with T2DM. Patients were divided into training and validation sets in a 7:3 ratio randomly. We utilized the least absolute shrinkage and selection operator (LASSO) regression, followed by multivariable logistic regression to determine independent risk factors. The performance of the nomogram was evaluated through receiver operating characteristic (ROC) curves, calibration curves, and decision curve analysis (DCA).
Results
Six independent factors were incorporated into the nomogram: diabetic peripheral neuropathy (DPN), coronary heart disease (CHD), serum albumin (ALB) levels, high-density lipoprotein cholesterol levels (HDLC), fasting blood glucose levels (FBG), and the neutrophil percentage-to-hemoglobin ratio (NPHR). This model demonstrated impressive discrimination, achieving an area under the curve (AUC) of 0.945 (95% confidence interval (CI) [0.9226–0.968]) in the training cohort and 0.941 (95% CI [0.9021–0.9789]) in the validation cohort, while the calibration curves illustrated a positive alignment between predictions and the observed data. Additionally, the DCA revealed clinical benefits.
Conclusion
This nomogram enables individualized risk stratification, guiding clinicians to prioritize high-risk patients for preventive care, thereby reducing diabetes-related complications and optimizing resource utilization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, The First Affiliated Hospital of Xi'an Medical University, Xi'an Medical University, Xi'an, Shanxi, China.
Zitieren
APA
Xie, C., & Li, Y. (2026). Development and validation of a nomogram model for predicting diabetic foot in type 2 diabetes. PeerJ, 14, e21584. https://doi.org/10.7717/peerj.21584
Vancouver
Xie C, Li Y. Development and validation of a nomogram model for predicting diabetic foot in type 2 diabetes. PeerJ. 2026;14:e21584. doi:10.7717/peerj.21584
BibTeX
@article{Xie2026,
author = {Xie, Chuanqing and Li, Ya},
title = {Development and validation of a nomogram model for predicting diabetic foot in type 2 diabetes},
journal = {PeerJ},
year = {2026},
volume = {14},
pages = {e21584},
doi = {10.7717/peerj.21584}
}
EUVIMED